Imidaprilat API is the active metabolite of Imidapril and a potent Angiotensin-Converting Enzyme (ACE) inhibitor used in cardiovascular pharmaceutical research and antihypertensive drug development. It inhibits the conversion of angiotensin I into angiotensin II, producing vasodilation, lowering peripheral vascular resistance, reducing aldosterone secretion, and effectively controlling blood pressure.
Imidaprilat plays an important role in ACE inhibitor research, pharmacokinetic studies, bioequivalence testing, impurity profiling, and formulation development. Due to its potent and selective ACE inhibition, it contributes significantly to cardiovascular drug research and development.
Manufactured under WHO-GMP-certified facilities, our Imidaprilat API is produced with stringent quality standards to ensure exceptional purity, stability, and batch-to-batch consistency. Every batch is supplied with comprehensive documentation including Certificate of Analysis (CoA), Material Safety Data Sheet (MSDS), Technical Data Sheet (TDS), and Product Specifications.
Imidaprilat API is used in cardiovascular pharmaceutical research, antihypertensive drug development, ACE inhibitor formulations, and analytical studies.
Imidaprilat inhibits the angiotensin-converting enzyme (ACE), reducing angiotensin II formation, relaxing blood vessels, lowering blood pressure, and reducing cardiac workload.
Yes. We provide CoA, MSDS, Technical Data Sheet (TDS), Product Specifications, and complete regulatory documentation with every shipment.
Yes. We supply Imidaprilat API in commercial quantities with worldwide export support and customized packaging.
Get Bulk Quote via WhatsApp